Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections

Post-marketing experience of vedolizumab: Pneumonia and other respiratory tract infections

Bibliographic Details
Main Authors:	Bhayat, F, Blake, A, Travis, S
Format:	Conference item
Published:	BMJ Publishing Group 2017

Similar Items

Post-marketing experience of vedolizumab in inflammatory bowel disease: analysis of pneumonia and other respiratory tract infections
by: Bhayat, F, et al.
Published: (2017)

Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment: clinical trial experience
by: Feagan, B, et al.
Published: (2017)

Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment for inflammatory bowel disease: clinical trial experience
by: Feagan, B, et al.
Published: (2017)

P500 Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics
by: Cohen, R, et al.
Published: (2019)

Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease
by: Travis, S, et al.
Published: (2018)

Respiratory tract infections in patients with inflammatory bowel disease: safety analyses from vedolizumab clinical trials
by: Feagan, BG, et al.
Published: (2018)

The safety profile of vedolizumab in ulcerative colitis and Crohn's disease: 4 years of global post-marketing data
by: Cohen, R, et al.
Published: (2019)

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
by: Card, T, et al.
Published: (2019)

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
by: Card, T, et al.
Published: (2019)

FACTORS ASSOCIATED WITH ACUTE RESPIRATORY TRACT INFECTION PNEUMONIA IN TODDLERS
by: Ayu Citra Gestari, et al.
Published: (2022-07-01)

The Experience of a Comparative Analysis of the Incidence of Pneumonia and Acute Respiratory Infections of the Upper Respiratory Tract after the Introduction of a System of Epidemiological Monitoring of Pneumonia
by: N. A. Kravchenko, et al.
Published: (2019-03-01)

Vedolizumab for the treatment of chronic pouchitis
by: Travis, S, et al.
Published: (2023)

Introducing vedolizumab to clinical practice: who, when and how?
by: Bryant, R, et al.
Published: (2015)

Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease.
by: Bye, W, et al.
Published: (2017)

Advanced and conventional molecular techniques in the diagnosis of Mycoplasma pneumoniae in patients with respiratory tract infection
by: Muntaha M. Hassan, et al.
Published: (2014-04-01)

pneumonia in childern admitted with lower respiratory tract infections.... A hospital based study
by: Muhi K. Al janabi, et al.
Published: (2013-01-01)

Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
by: Eva Hüttemann, et al.
Published: (2023-12-01)

IMMUNOMODULATORY THERAPY IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND UPPER RESPIRATORY TRACT
by: E. F. Glushkova, et al.
Published: (2016-12-01)

Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study
by: Abdulaziz Saad Alshahrani, et al.
Published: (2023-09-01)

MUCOSAL MICROFLORA AND INNATE IMMUNITY OF UPPER RESPIRATORY TRACT IN INTRAUTERINE FOETAL INFECTION AND PNEUMONIA OF NEONATES
by: O. A. Svitich, et al.
Published: (2016-04-01)

Antibiotic Prescribing for Lower Respiratory Tract Infections and Community-Acquired Pneumonia: An Italian Pediatric Emergency Department’s Real-Life Experience
by: Luca Pierantoni, et al.
Published: (2023-09-01)

International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
by: Williamson, K, et al.
Published: (2018)

ELIMINATION THERAPY OF UPPER RESPIRATORY TRACT MUCOUS TISSUES AS A MEAN OF PROPHYLAXIS OF INFUENZA AND OTHER ACUTE VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN
by: T.I. Garaschenko, et al.
Published: (2006-01-01)

ELIMINATION THERAPY OF UPPER RESPIRATORY TRACT MUCOUS TISSUES AS A MEAN OF PROPHYLAXIS OF INFUENZA AND OTHER ACUTE VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN
by: T.I. Garaschenko, et al.
Published: (2006-03-01)

The upper and lower respiratory tract microbiome in severe aspiration pneumonia
by: Georgios D. Kitsios, et al.
Published: (2023-06-01)

Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya.
by: Munywoki, P, et al.
Published: (2013)

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.
by: Schuetz, P, et al.
Published: (2010)

Upper respiratory tract infection.
by: Del Mar, C, et al.
Published: (2002)

Respiratory-tract infections in the tropics.
by: Warrell, D
Published: (1975)

Upper respiratory tract infection.
by: Del Mar, C, et al.
Published: (2003)

Upper respiratory tract infection.
by: Mar, D, et al.
Published: (2002)

RESPIRATORY-TRACT INFECTIONS IN TROPICS
by: Warrell, D
Published: (1975)

Upper respiratory tract infection.
by: Del Mar, C, et al.
Published: (2003)

Respiratory Tract Infections in Children
by: Tobias Tenenbaum
Published: (2021-12-01)

Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
by: Çağdaş Erdoğan, et al.
Published: (2022-10-01)

Risk Factors for Lower Respiratory Tract Infection and Recurrent Lower Respiratory Tract Infection in Children
by: İlknur Sürücü Kara, et al.
Published: (2024-01-01)

Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study
by: Moore, M, et al.
Published: (2017)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

PROPHYLAXIS OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGIC DISEASES OF RESPIRATORY TRACT
by: L.F. Kaznacheeva, et al.
Published: (2010-01-01)

PROPHYLAXIS OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGIC DISEASES OF RESPIRATORY TRACT
by: L.F. Kaznacheeva, et al.
Published: (2010-09-01)